- Home
- PROK vs AEVA Comparison
PROK vs AEVA Comparison
Compare PROK & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- AEVA
- Stock Information
- Founded
- PROK 2015
- AEVA 2019
- Country
- PROK United States
- AEVA United States
- Employees
- PROK N/A
- AEVA N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- AEVA Auto Parts:O.E.M.
- Sector
- PROK Health Care
- AEVA Consumer Discretionary
- Exchange
- PROK Nasdaq
- AEVA Nasdaq
- Market Cap
- PROK 186.8M
- AEVA 192.9M
- IPO Year
- PROK N/A
- AEVA N/A
- Fundamental
- Price
- PROK $1.05
- AEVA $3.13
- Analyst Decision
- PROK Buy
- AEVA Buy
- Analyst Count
- PROK 5
- AEVA 5
- Target Price
- PROK $4.50
- AEVA $10.53
- AVG Volume (30 Days)
- PROK 546.9K
- AEVA 324.7K
- Earning Date
- PROK 03-21-2025
- AEVA 05-06-2025
- Dividend Yield
- PROK N/A
- AEVA N/A
- EPS Growth
- PROK N/A
- AEVA N/A
- EPS
- PROK N/A
- AEVA N/A
- Revenue
- PROK N/A
- AEVA $7,980,000.00
- Revenue This Year
- PROK N/A
- AEVA $109.02
- Revenue Next Year
- PROK N/A
- AEVA $63.91
- P/E Ratio
- PROK N/A
- AEVA N/A
- Revenue Growth
- PROK N/A
- AEVA 176.22
- 52 Week Low
- PROK $0.98
- AEVA $2.20
- 52 Week High
- PROK $4.44
- AEVA $7.05
- Technical
- Relative Strength Index (RSI)
- PROK 23.63
- AEVA 27.62
- Support Level
- PROK $0.98
- AEVA $3.12
- Resistance Level
- PROK $1.32
- AEVA $3.34
- Average True Range (ATR)
- PROK 0.11
- AEVA 0.22
- MACD
- PROK -0.04
- AEVA -0.07
- Stochastic Oscillator
- PROK 10.61
- AEVA 11.68
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.